You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Central Serous Chorioretinopathy

Showing 1 - 25 of 7,469
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Central Serous Chorioretinopathy Trial in Bordeaux (micropulse laser)

Not yet recruiting
  • Central Serous Chorioretinopathy
  • micropulse laser
  • Bordeaux, France
    CHU Bordeaux
Jan 9, 2023

Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta

Completed
  • Central Serous Chorioretinopathy
  • Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy
  • Cairo, Egypt
    Kasr alainy faculty of medicine
May 5, 2023

Central Serous Chorioretinopathy Trial (100µm laser spot diameter micropulse laser, 200µm laser spot diameter micropulse laser)

Not yet recruiting
  • Central Serous Chorioretinopathy
  • 100μm laser spot diameter micropulse laser
  • 200μm laser spot diameter micropulse laser
  • (no location specified)
Jan 13, 2023

Choroidal Blood Flow in Acute and Chronic Central Serous

Recruiting
  • Central Serous Chorioretinopathy
  • Stavanger, Norway
    Stavanger University Hospital, Department of Ophthalmology
Oct 18, 2022

Chronic Central Serous Chorioretinopathy Trial in Nijmegen, Rotterdam (steroid eye drops, Placebo)

Not yet recruiting
  • Chronic Central Serous Chorioretinopathy
  • steroid eye drops
  • Placebo
  • Nijmegen, Netherlands
  • +1 more
Nov 21, 2022

Acute Central Serous Retinopathy With Subretinal Fluid Trial in Minya (Micropulse laser)

Completed
  • Acute Central Serous Retinopathy With Subretinal Fluid
  • Micropulse laser
  • Minya, Minia, Egypt
    Minia University Hospital
Sep 8, 2022

Central Serous Chorioretinopathy Trial in East Melbourne, Glen Iris (2RT subthreshold nanosecond laser - active, 2RT

Recruiting
  • Central Serous Chorioretinopathy
  • 2RT subthreshold nanosecond laser - active
  • 2RT subthreshold nanosecond laser - sham
  • East Melbourne, Victoria, Australia
  • +1 more
Oct 17, 2022

Acute Central Serous Chorioretinopathy Trial in Guangzhou (577-MPL, HD-PDT)

Completed
  • Acute Central Serous Chorioretinopathy
  • 577-MPL
  • HD-PDT
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Apr 4, 2022

Central Serous Chorioretinopathy, Therapy, Photodynamic Trial in Beijing (50% dose of photodynamic therapy, 70% dose of

Recruiting
  • Central Serous Chorioretinopathy
  • Therapy, Photodynamic
  • 50% dose of photodynamic therapy
  • 70% dose of photodynamic therapy
  • Beijing, Beijing, China
    Peking University People's Hospital
May 21, 2022

Central Serous Chorioretinopathy Trial in Hong Kong

Recruiting
  • Central Serous Chorioretinopathy
    • Hong Kong, Hong Kong
    • +2 more
    Apr 19, 2022

    Age-Related Macular Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy Trial in New York (OCT Imaging Using

    Not yet recruiting
    • Age-Related Macular Degeneration
    • +5 more
    • OCT Imaging Using Device N
    • OCT Imaging Using Device C
    • New York, New York
      NYU Langone Health
    Jan 6, 2023

    Chorioretinopathy, Central Serous Trial in Shiraz (Crocin, Placebo)

    Recruiting
    • Chorioretinopathy, Central Serous
    • Shiraz, Fars, Iran, Islamic Republic of
      Shiraz University of Medical Sciences
    Oct 27, 2021

    Eplerenone Versus PDT: Comparative Study by OCTA

    Completed
    • Central Serous Chorioretinopathy
    • Eplerenone
    • The patients underwent half fluence photodynamic therapy for 6 months
    • (no location specified)
    Oct 21, 2021

    Central Serous Chorioretinopathy, Irvine-Gass Syndrome, Pars Planitis Trial in Banha (Triamcinolone Acetonide)

    Recruiting
    • Central Serous Chorioretinopathy
    • +3 more
    • Triamcinolone Acetonide
    • Banhā, QA, Egypt
      Ahmed Abdelshafy
    Apr 13, 2022

    Choroidal Ischemia, Vitelliform Macular Dystrophy, Age-related Macular Degeneration Trial in New York (drug, other, diagnostic

    Recruiting
    • Choroidal Ischemia
    • +4 more
    • New York, New York
      Columbia University Medical Center, Edward Harkness Eye Institut
    May 2, 2022

    OCT in Rare Chorioretinal Diseases

    Recruiting
    • Retinal Artery Occlusions
    • +4 more
      • Portland, Oregon
        Casey Eye Institute, Oregon Health & Science University
      Jul 13, 2021

      Association Between CRSA and OSA

      Recruiting
      • Chorioretinopathy
      • Obstructive Sleep Apnea
        • Poitiers, France
          CHU de Poitiers
        Apr 13, 2021

        Multiple Eye Fundus Diseases From Color Fundus Photograph

        Completed
        • Diabetic Retinopathy
        • +12 more
        • Software assisted imaging diagnosis
        • BeiJing, Beijing, China
        • +4 more
        Dec 28, 2021

        Central Serous Chorioretinopathy, Age Related Macular Degeneration, Idiopathic Poplypoidal Choroidal Vasculopathy Trial in

        Recruiting
        • Central Serous Chorioretinopathy
        • +2 more
        • Toronto, Ontario, Canada
          Sunnybrook Research Institute
        Jan 25, 2021

        Pilot Study on Deep Learning in the Eye

        Not yet recruiting
        • Central Serous Chorioretinopathy
        • +2 more
        • Image classification using deep learning algorithm
        • (no location specified)
        Jan 5, 2021

        Central Serous Chorioretinopathy, Chronic Central Serous Chorioretinopathy Trial in Ankara (Source of growth factors: autologous

        Completed
        • Central Serous Chorioretinopathy
        • Chronic Central Serous Chorioretinopathy
        • Source of growth factors: autologous platelet-rich plasma (aPRP) + repetitive electromagnetic stimulation for iontophoresis
        • Ankara, Türkiye, Turkey
          Ankara University Biotechnology Institute
        Jan 9, 2020

        Chronic Central Serous Chorioretinopathy Trial in Amsterdam, Leiden, Nijmegen (Eplerenone, Photodynamic therapy)

        Unknown status
        • Chronic Central Serous Chorioretinopathy
        • Amsterdam, Netherlands
        • +2 more
        Oct 22, 2019

        Central Serous Chorioretinopathy Trial in Besançon (RTX1 IMAGIN EYE retinal camera)

        Terminated
        • Central Serous Chorioretinopathy
        • RTX1 IMAGIN EYE retinal camera
        • Besançon, France
          CHU Besançon
        Sep 13, 2019

        Central Serous Choroidopathy Trial in Wenzhou (577-MPL, TLT)

        Completed
        • Central Serous Choroidopathy
        • 577-MPL
        • TLT
        • Wenzhou, Zhejiang, China
          The eye of Wenzhou Medical University
        Jul 17, 2019

        Macular Edema, Central Serous Chorioretinopathy, Retinal Vein Occlusion Trial in Bern (Selective retinal pigment epithelium

        Suspended
        • Macular Edema
        • +4 more
        • Selective retinal pigment epithelium laser therapy using the R:GEN Laser System
        • Bern, Switzerland
          Department of Ophthalmology, Bern University Hospital
        Oct 9, 2019